Apoptosis profiles in benign prostatic hyperplasia: Close associations of cell kinetics with percent area density of histologic composition

Urology

Volumn 68, Issue 4, 2006, Pages 905-910

  Zhang, Xianghua ^a   Zhang, Qian ^a   Zhang, Zheng ^a   Na, Yanqun ^a   Guo, Yinglu ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; KI 67 ANTIGEN; PROTEIN BCL 2;

ADULT; AGED; APOPTOSIS; ARTICLE; CELL ASSAY; CELL DENSITY; CELL PROLIFERATION; COMPUTER ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; NICK END LABELING; PRIORITY JOURNAL; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SAMPLE SIZE; STAINING; STROMA; TISSUE SECTION;

AGED; APOPTOSIS; CASPASE 3; CASPASES; CELL PROLIFERATION; EPITHELIUM; HUMANS; MALE; MIDDLE AGED; PROSTATIC HYPERPLASIA; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 33750339698     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2006.05.013     Document Type: Article

References (23)

1. Foster C.S. Pathology of benign prostatic hyperplasia. Prostate Suppl 9 (2000) 4-14
2. Claus S., Berges R., Senge T., et al. Cell kinetics in epithelium and stroma of benign prostatic hyperplasia. J Urol 158 (1997) 217-221
3. Kyprianou N., Tu H., Jacobs S.C., et al. Apoptotic versus proliferative activities in human benign prostatic hyperplasia. Hum Pathol 27 (1996) 668-675
4. Colombel M., Vacherot F., Diez S.G., et al. Zonal variation of apoptosis and proliferation in the normal prostate and in benign prostatic hyperplasia. Br J Urol 82 (1998) 380-385
5. Thompson T.C., and Yang G. Regulation of apoptosis in prostatic disease. Prostate Suppl 9 (2000) 25-28
6. Hockenbery D., Nunez G., Milliman C., et al. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 22 (1990) 334-336
7. Bonkhoff H. Role of the basal cells in premalignant changes of the human prostate: a stem cell concept for the development of prostate cancer. Eur Urol 30 (1996) 201-205
8. Hengartner M.O., and Horvitz H.R. C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2. Cell 76 (1994) 665-676
9. Yuan J., Shaham S., Ledoux S., et al. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme. Cell 75 (1993) 641-652
10. Nunez G., Benedict M.A., Hu Y., et al. Caspases: the proteases of the apoptotic pathway. Oncogene 17 (1998) 3237-3245
11. Liu X., Zou H., Slaughter C., et al. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 89 (1997) 175-184
12. Enari M., Sakahira H., Yokoyama H., et al. A caspase activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391 (1998) 43-50
13. Shariat S.F., Ashfaq R., Roehrborn C.G., et al. Expression of survivin and apoptotic biomarkers in benign prostatic hyperplasia. J Urol 174 (2005) 2046-2050
14. Borre M., Stausbol-Gron B., and Overgaard J. p53 accumulation associated with bcl-2, the proliferation marker MIB-1 and survival in patients with prostate cancer subjected to watchful waiting. J Urol 164 (2000) 716-721
15. O'Neill A.J., Boran S.A., O'Keane C., et al. Caspase 3 expression in benign prostatic hyperplasia and prostate carcinoma. Prostate 47 (2001) 183-188
16. Zhang X., Na Y., and Guo Y. Biological feature of prostatic hyperplasia developed in spontaneously hypertensive rats. Urology 63 (2004) 983-988
17. Shapiro E., Becich M.J., Hartanto V., et al. The relative proportion of stromal and epithelial hyperplasia is related to the development of symptomatic benign prostate hyperplasia. J Urol 147 (1992) 1293-1297
18. Shapiro E., Hartanto V., and Lepor H. The response to alpha blockade in benign prostatic hyperplasia is related to the percent area density of prostate smooth muscle. Prostate 21 (1992) 297-307
19. McDonnell T.J., Troncoso P., Brisbay S.M., et al. Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res 52 (1992) 6940-6944
20. Krajewska M., Wang H.G., Krajewski S., et al. Immunohistochemical analysis of in vivo patterns of expression of CPP32 (caspase-3), a cell death protease. Cancer Res 57 (1997) 1605-1613
21. Boudon C., Rodier G., Lechevallier E., et al. Secretion of insulin-like growth factors and their binding proteins by human normal and hyperplastic prostatic cells in primary culture. J Clin Endocrinol Metab 81 (1996) 612-617
22. Burnett A.L., Maguire M.P., Chamness S.L., et al. Characterization and localization of nitric oxide synthase in the human prostate. Urology 45 (1995) 435-439
23. Krieg M., Nass R., and Tunn S. Effect of aging on endogenous level of 5a-dihydrotestosterone, testosterone, estradiol, and estrone in epithelium and stroma of normal and hyperplastic human prostate. J Clin Endocrinol Metab 77 (1993) 375-381